Israeli medical technology company P-Cure Ltd has signed an agreemnt with Indian healthcare company ARISTION Proton Center Private Limited to deploy P-Cure’s compact, synchrotron-based proton therapy systems in India. ARISTION plans to invest of approximately ₹1,900 crore to build dedicated proton therapy infrastructure across the country.
Proton therapy is an advanced, precise type of radiation treatment that uses a beam of high-energy protons instead of traditional X-rays to destroy cancer cells. The first centre will be established at Sentient Health City, Bengaluru, followed by centres in Kochi and a third major metropolitan city.
Across the network, care will be built on an integrated AI and augmented intelligence layer.
Dr Lohith G Reddy, CMD & Radiation Oncologist, ARISTION Proton Center, said, “India already delivers world-class medical care. What has been missing is proton & ion precision treatment at the scale a nation of 1.4 billion deserves — and that is the opportunity this partnership unlocks. P-Cure’s compact system gives us the economics to build a national network, delivering the world’s most advanced radiation therapy, which is accessible.”
The agreement marks the first deployment of P-Cure’s ultracompact proton therapy system in India. The planned investment is intended to fund an integrated network of centres rather than standalone machine installations, with affordability and geographic access positioned at the centre of the model.